Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 8.45
-0.11 (-1.29%)
Apr 8, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 138.35 million as of April 8, 2026. Its market cap has decreased by -16.89% in one year.
Market Cap
138.35M
Enterprise Value
136.66M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.45
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 138.35M, an increase of 48.74%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 138.35M | 22.64% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 529.45M |
| Captor Therapeutics Spolka Akcyjna | 446.72M |
| Bioceltix | 406.76M |
| BIOTON | 369.22M |
| Synthaverse | 260.44M |
| Molecure | 108.78M |
| NanoGroup | 81.91M |
| Poltreg | 81.84M |